DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Acetylleucine
Acetylleucine
Automated Annotation of Structurally Uncharacterized Metabolites in Human Metabolomics Studies by Systems Biology Models
Title Effects of N-Acetyl-Leucine and Its Enantiomers in Niemann-Pick
Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
)&F1y3x PHARMACEUTICAL APPENDIX to THE
(12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Dizziness & Vertigo
Review of Existing Classification Efforts
Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……
Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
(12) Patent Application Publication (10) Pub. No.: US 2005/0182097 A1 Zeldis Et Al
Biochemical Differences in Cerebrospinal Fluid Between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
Current Perspectives in the Pharmacotherapy of Vertigo Current Perspectives in the Pharmacotherapy of Vertigo
Case No COMP/M.7379 - MYLAN/ ABBOTT EPD-DM
(12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
Customs Tariff - Schedule Xxi - 1
Top View
Efficacy of Acetylleucine in Vertigo and Dizziness
Australian Statistics on Medicines 2009
Charles M. Lizza William C. Baton Sarah A. Sullivan One
TOHTUNUTTUUUS009993467B2 (12 ) United States Patent ( 10 ) Patent No
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Pharmaceutical Appendix to the Tariff Schedule 2
Pharmaceuticals Appendix
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
20170210 Study SENS 111-201 2.0 CT.Gov
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving